IN8BIO, INC. - INAB

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$7.441M
QoQ value delta ($000)
+$5.322M (+251.16%)
Implied price effect (QoQ)
+6.65%
Shares
Total shares
3,227,723
QoQ shares delta
+2,247,404 (+229.25%)
Total shares held by funds (by quarter)

Market chart (INAB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Alyeska Investment Group, L.P. 2,231 957,484 0.01%
FRANKLIN RESOURCES INC 2,048 914,531 0.0%
683 Capital Management, LLC 1,695 724,637 0.07%
BIOS Capital Management, LP 592 253,417 0.72%
Stonepine Capital Management, LLC 385 164,893 0.28%
TWO SIGMA ADVISERS, LP 85 36,351 0.0%
VANGUARD GROUP INC 66 28,348 0.0%
TWO SIGMA INVESTMENTS, LP 66 28,214 0.0%
Texas Capital Bank Wealth Management Services Inc 55 23,750 0.0%
GEODE CAPITAL MANAGEMENT, LLC 49 20,969 0.0%
CAPTRUST FINANCIAL ADVISORS 42 18,295 0.0%
NORTHERN TRUST CORP 40 17,400 0.0%
XTX Topco Ltd 39 17,043 0.0%
HRT FINANCIAL LP 34 14,913 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 6 2,785 0.0%
Tower Research Capital LLC (TRC) 5 2,450 0.0%
JONES FINANCIAL COMPANIES LLLP 2 1,228 0.0%
UBS Group AG 1 777 0.0%
BANK OF AMERICA CORP /DE/ 0 37 0.0%
MORGAN STANLEY 0 34 0.0%
Rockefeller Capital Management L.P. 0 83 0.0%
BlackRock, Inc. 0 84 0.0%